Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

Similar articles for PubMed (Select 10711322)

1.

The effect of a closed formulary on prescription drug use and costs.

Motheral BR, Henderson R.

Inquiry. 1999-00 Winter;36(4):481-91.

PMID:
10711322
2.

The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?

Huskamp HA, Epstein AM, Blumenthal D.

Health Aff (Millwood). 2003 May-Jun;22(3):149-58.

3.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
4.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571
5.
6.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

7.

Prescription drugs: recent trends in utilization, expenditures, and coverage.

Sethi RC.

EBRI Issue Brief. 2004 Jan;(265):1-35. No abstract available.

PMID:
14969223
8.

The effect of a three-tier formulary on antidepressant utilization and expenditures.

Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.

J Ment Health Policy Econ. 2008 Jun;11(2):67-77.

PMID:
18509214
9.
10.

Controlling prescription drug expenditures: a report of success.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.

Am J Manag Care. 2007 Aug;13(8):473-80.

11.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

12.
13.

Beyond survey data: a claims-based analysis of drug use and spending by the elderly.

Steinberg EP, Gutierrez B, Momani A, Boscarino JA, Neuman P, Deverka P.

Health Aff (Millwood). 2000 Mar-Apr;19(2):198-211.

14.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
16.

Approaches to pharmacy benefit management and the impact of consumer cost sharing.

Olson BM.

Clin Ther. 2003 Jan;25(1):250-72. Review.

PMID:
12637125
17.

Managing prescription drug costs.

Sica JM.

Empl Benefits J. 2001 Mar;26(1):35-40.

PMID:
11272515
18.
19.

Explaining drug spending trends: does perception match reality?

Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S.

Health Aff (Millwood). 2000 Mar-Apr;19(2):231-9.

20.

Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.

Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML.

Inquiry. 1993 Summer;30(2):199-207.

PMID:
8314608
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk